Polaris Genomics
PrivateLast Round
Debt
Sep 3, 2025
Total Funding Raised
$5.66M
Company Overview
Polaris Genomics is a biotechnology company that develops AI-powered genomic diagnostics and therapeutics for mental health and neuropsychiatric conditions.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Mental Health, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Polaris Genomics Comparables
Compare Polaris Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivid Genomics | 81% | |
| Circular Genomics | 78% | |
| MindX Sciences | 78% |
Polaris Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 3, 2025 | ||||
| Seed | Nov 1, 2023 | ||||
| Grant | Nov 2, 2022 | ||||
| Grant | Sep 20, 2022 | ||||
| Grant | Jul 19, 2022 | ||||
Grant | Jan 5, 2022 |
Key People
Founding team and executive leadership
Polaris Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Seed |
| Wavemaker Three-Sixty Health | Seed |
| Maryland Industrial Partnerships (MIPS) | Grant |
| Viking Global Investors | Seed |
| AFVentures | Grant |
| Illumina Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors increased 87% MoM.
- Sep 3, 2025
$250K debt round completed.
Polaris Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Polaris Genomics's valuation, stock price, and market status.
Is Polaris Genomics a public or private company?
Polaris Genomics is a private company.
What is the current stock price of Polaris Genomics?
Polaris Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is Polaris Genomics worth (valuation)?
Valuation information for Polaris Genomics is not publicly available.
Can I buy Polaris Genomics stock?
Polaris Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Polaris Genomics's last funding round?
Polaris Genomics's most recent funding round was Seed on November 1, 2023.
Who are the main investors in Polaris Genomics?
Key investors in Polaris Genomics include Sanford Health, Illumina Accelerator.
Will Polaris Genomics IPO soon?
No public IPO plans have been announced for Polaris Genomics.
How can I track Polaris Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Polaris Genomics's secondary market activity and sign up for updates.